8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):June 16, 2023

Purple Innovation, Inc.

(Exact Name of Registrant as Specified in itsCharter)

Registrant’s telephone number, including

area code: (801) 756-2600

N/A

(Former name or former address, if changed sincelast report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTIONOF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On June 16, 2023, at the Annual Meeting of Stockholders (the “Annual Meeting”) of Purple Innovation, Inc. (the “Company”), the Company’s stockholders approved an amendment and restatement of the Purple Innovation, Inc. 2017 Equity Incentive Plan (the “Amended and Restated Plan”). The Amended and Restated Plan, among other changes, extended for the plan’s term for five additional years, to 2033, increased the annual limitation on individual awards, including awards to the Company’s executive officer, to 1,500,000 shares, clarified the treatment of awards in the event of a change in control, and increased the number of shares of Class A Common Stock authorized for issuance under the 2017 Plan by 3,800,000 shares (resulting in a total authorized reserve of 7,900,000 shares).

A summary of the Amended and Restated Plan appears on pages 59 through 69 of the Company’s proxy statement filed with the Securities and Exchange Commission on May 23, 2023, in connection with the Annual Meeting. The foregoing description of the Amended and Restated Plan and the summary included in the Company’s Proxy Statement are qualified in their entirety by reference to the Amended and Restated Plan, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

On June 16, 2023, the following proposals were approved by the Company’s stockholders at the Annual Meeting:

1

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

The following exhibit is filed herewith:

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

3